Laurus Investment Counsel Inc. Makes New $5.42 Million Investment in Integer Holdings Co. (NYSE:ITGR)

Laurus Investment Counsel Inc. bought a new position in Integer Holdings Co. (NYSE:ITGR) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 40,915 shares of the medical equipment provider’s stock, valued at approximately $5,422,000. Integer comprises about 2.8% of Laurus Investment Counsel Inc.’s portfolio, making the stock its 11th largest position. Laurus Investment Counsel Inc. owned 0.12% of Integer as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of the stock. R Squared Ltd acquired a new position in Integer during the 4th quarter worth $44,000. KBC Group NV lifted its stake in shares of Integer by 83.3% during the fourth quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock valued at $212,000 after acquiring an additional 726 shares during the period. Blue Trust Inc. boosted its holdings in Integer by 4.4% in the fourth quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider’s stock valued at $220,000 after acquiring an additional 71 shares during the last quarter. Tributary Capital Management LLC increased its position in Integer by 0.8% in the fourth quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider’s stock worth $38,103,000 after purchasing an additional 2,289 shares during the period. Finally, Exchange Traded Concepts LLC raised its holdings in Integer by 2.6% during the 4th quarter. Exchange Traded Concepts LLC now owns 5,800 shares of the medical equipment provider’s stock worth $769,000 after purchasing an additional 145 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Down 0.9 %

Shares of Integer stock opened at $142.29 on Friday. The company has a market capitalization of $4.77 billion, a P/E ratio of 43.92, a price-to-earnings-growth ratio of 1.82 and a beta of 1.12. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The business has a 50-day moving average of $137.85 and a two-hundred day moving average of $130.36. Integer Holdings Co. has a 1 year low of $94.56 and a 1 year high of $146.36.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on ITGR. Piper Sandler reaffirmed an “overweight” rating and issued a $140.00 target price (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Truist Financial lifted their target price on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. Citigroup lifted their price objective on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Finally, KeyCorp increased their target price on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $146.56.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.